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Abstract
Infantile spasms respond to ACTH, and levels of the hormone in cerebrospinal fluid of untreated
infants with this disorder were found to be lower than in age-matched controls. In this study we
analyzed cerebrospinal fluid Cortisol and ACTH using improved immunoassays in a larger cohort
of infants with infantile spasms. Analysis of 20 patients and 15 age-matched controls revealed
significantly lower levels of both ACTH and Cortisol in the cerebrospinal fluid. These data,
combined with the efficacy of ACTH and glucocorticoids for infantile spasms, support an
involvement of the brain-adrenal-axis in this disorder.
Introduction
The etiology of infantile spasms (IS) has not been resolved [1–3]. The seizures are treated
with ACTH or prednisone, with a response rate of 50–88% [1,3–5]. The mechanisms by
which these hormones suppress the seizures and normalize the EEG are not fully
understood, yet may help clarify the pathophysiology of this disorder [2,3]. The “all-or-
none” disappearance of spasms often within days, and the persistence of the effect upon
hormone withdrawal, is consistent with a neuroendocrine mechanism [3,6]. We have
previously found a low cerebrospinal fluid (CSF) level of ACTH in untreated infants with IS
compared with age-matched controls [6]. A trend toward decreased Cortisol did not reach
statistical significance (P = .08), but Cortisol values were available only from 12 patients
and 9 controls. This report summarizes the study of CSF Cortisol and ACTH in a larger
cohort of patients with IS and age-matched controls.
Methods
Patients and Controls
Patients consisted of 20 infants (3–14 months old) fulfilling criteria for IS [7], all with
hypsarrhythmia or modified hypsarrhythmia at the time of spinal tap (Table 1). Four infants
with no etiology for their IS and a normal neurodevelopmental assessment were defined as
cryptogenic or idiopathic [8]. Infants with abnormal neurodevelopmental examination and
no proven etiology were classified as “symptomatic with unknown etiology.” Patients
underwent a lumbar puncture as part of an evaluation for the etiology of the syndrome. No
patient had received ACTH or prednisone prior to the procedure.
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Age-matched controls were infants undergoing lumbar puncture for various reasons (Table
2). The clinical characteristics of both groups of patients are delineated in Tables 1 and 2;
five patients and controls were included in a previous report [6]. The study of CSF was
approved by the Internal Review Board for human studies of Childrens Hospital Los
Angeles, and Kaiser-Permanente. Los Angeles.
CSF Handling, Hormone Assays, and Statistical Considerations
CSF was collected in ice-chilled tubes and immediately stored at −80°C. Aliquots were
lyophilized for Cortisol assay; for ACTH, improved methods did not require lyophylization.
New CSF samples and those from previously reported infants (five each, patients and
controls) were assayed together.
ACTH samples were subjected to a two-point antibody ACTH assay (Allegro ACTH IRMA.
Nichols Institute, San Juan Capistrano. CA). Assay sensitivity was 5 pg/ml; interassay
variability was 8%. Cortisol was measured using a commercial radioimmunoassay (6, ICN
Irvine, CA).
Results
Individual values of CSF ACTH and Cortisol are shown in Tables 1 and 2. Mean age of IS
infants was 6.73 ± 0.6 months and of controls 7.8 ± 1.9 months (difference not significant).
Median ages were 5 months for controls and 6 months for the IS group. This discrepancy
reflects a wider age spread in the controls.
Summary and statistical analyses of hormonal values are presented in Table 3. Both ACTH
and Cortisol levels were markedly and significantly reduced in IS patients as compared with
age-matched controls. The larger sample size confirmed the trend to lower Cortisol levels in
patients. The more reliable IRMA technique for ACTH (compared with radioimmunoassay)
validated the lower levels in infants with IS and resulted in a smaller variance. This
increased statistical significance (P = .0029, Mann-Whitney U test).
Among patients with IS, 4 of 21 (19%) were cryptogenic, with a normal
neurodevelopmental examination. There was a trend toward lower Cortisol levels in this
group (1.25 ± 0.46 ng/ml) compared with infants with abnormal examination regardless of
the presence of a defined etiology (1.57 ± 0.46 ng/ml). ACTH levels in 3 normal infants
(30.33 pg/ml) did not distinguish them from those with abnormal neurologic examinations.
Discussion
In a cohort of untreated infants with IS, CSF ACTH and Cortisol were lower than in age-
matched controls, suggesting an abnormal brain-adrenal axis. CSF ACTH does not reflect
peripheral levels, and may be a marker for central nervous system abnormalities of the
CRH-ACTH-cortisol cascade. The findings do not distinguish between under-production of
ACTH and Cortisol, as suggested by Riikonen [2], or downregulation of ACTH production
due to chronic exposure to the ACTH stimulator, corticotropin releasing hormone (CRH)
[3,8].
Chronic infusion of synthetic CRH into the cerebral ventricles of the rat leads to
desensitization of CRH receptors and to lower CSF ACTH [9]. Our findings are thus
consistent with an increase of CRH in the central nervous system of patients with IS. CRH is
a convulsant, with strong age-specificity to infancy [10]. One may speculate that CRH plays
an epileptogenic role in IS and is associated with decreased CSF ACTH and Cortisol [3,6].
As CRH receptors peak in infancy [11], seizures may only occur at that age. The typical
Baram et al. Page 2




response of IS to ACTH, in view of general resistance to conventional antiepileptic drugs, is
concordant with this hypothesis. Further, the unique response pattern of the seizures to
hormonal therapy (abrupt, “all-or-none” disappearance within days, without recurrence on
discontinuation of therapy) suggests neuroendocrine mechanisms for ACTH/prednisone
efficacy. This may involve a negative feedback suppression of the synthesis or secretion of
CRH [3,6], which lasts throughout the period of high CRH receptor abundance [11].
Unlike others [12; R. Riikonen, personal communication], we did not find significant
differences between infants with “cryptogenic” and “symptomatic” IS. Our study, like other
reports, suffers from the small numbers of truly normal (“idiopathic-cryptogenic”) infants.
In summary, untreated patients with IS have significantly low CSF ACTH and Cortisol. The
relevance of this finding to the etiology of the disorder deserves further study. We are
assessing the effect of hormonal therapy on these CSF parameters.
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Table 1
Characteristics of patients with infantile spasms
No. Age (mos)/Sex Etiology ACTH (pg/ml) Cortisol (ng/ml)
1 6/M Brain malformation 19 1.0
2 3/F Unknown, abnormal 34 3.37
3 10/M Unknown, abnormal 45 —
4 6/F Cryptogenic, normal 33 2.5
5 7/F Tuberous sclerosis 27 1.2
6 10/F Cryptogenic, normal 24 1.75
7 6/F Cryptogenic, normal 34 0.37
8* 5/F Unknown, abnormal 48 —
9 3.5/M Congenital cytomegalovirus 24 1.25
10 9/M Unknown, abnormal 20 —
11 8/M Unknown, abnormal 21 —
12 6/F Multiple anomalies 21 0.87
13 6/M Down syndrome 40 1.25
14* 6/F Congenital malformation 24 1.25
15* 3/M Unknown, abnormal 12 1.25
16* 12/M Congenital hydrocephalus 50 2.75
17 5/F Bacterial meningitis 26 0.9
18* 11/M Congenital malformation 38 0.55
19 6/M Unknown, abnormal 29 3.25
20 6/F Cryptogenic, normal — 0.37
*
Reported previously [6].
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Table 2
Characteristics of control infants
No. Age (mos)/Sex Diagnosis ACTH (pg/ml) Cortisol (ng/ml)
1 14/F Seizures 27 —
2 17/M Acute ataxia 58 2
3 3/M Seizures 45 —
4 5/F Status epilepticus 34 1.6
5 2/F “Rule-out herpes” 33 2.5
6 2.5/M Seizures 38 1.35
7 28/M Seizures, delayed 46 5.25
8 12/M Seizures 28 1.1
9 2/M Seizures 36 1.6
10 3.5/M Seizures 49 4.0
11* 18/M Ataxia 77 —
12* 1/M Seizures 60 2.9
13* 5/M Viral syndrome 42 3.75
14* 10/M Febrile seizure 33 6.0
15* 3/M Seizures 75 1.63
*
Reported previously [6].
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Table 3
CSF hormones in infantile spasms: Summary
Hormone Controls (n) IS(n) P
Cortisol (ng/ml) 2.81 ± 0.46 (12) 1.49 ± 0.24 (16)
.0094*
ACTH (pg/ml) 45.6 ± 4.0 (15) 29.9 ± 2.4 (19)
.0029*
Values are means ± standard error.
*
Two-tailed; Mann-Whitney U test.
Abbreviation:
IS = Infantile spasms
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